Allogene Therapeutics, Inc.
ALLO
Revenue
0.00
0.000.00%
3 Months ChangeAssets
548.71M
▼-40.41M▼-6.86%
3 Months ChangeLiabilities
126.53M
▲1.16M▲0.9244%
3 Months ChangeFree Cash Flow
-55.91M
▲11.77M▲17.39%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-07
Form 8-K
ID: 0001737287-24-000062
2024-08-07
Form 10-Q
ID: 0001737287-24-000056
2024-08-07
Form 8-K
ID: 0001737287-24-000055
2024-06-10
Form 8-K
ID: 0001737287-24-000050
2024-05-31
Form 8-K
ID: 0001737287-24-000046
2024-05-14
Form 8-K
ID: 0001193125-24-138316
2024-05-13
Form 10-Q
ID: 0001737287-24-000041
2024-05-13
Form 8-K
ID: 0001737287-24-000040
2024-03-14
Form 8-K
ID: 0001737287-24-000019
2024-02-16
Form 8-K
ID: 0001193125-24-038107